中文
Pyridinium tribromide is a crystalline product widely used in fine chemicals and organic synthesis. Compared to traditional liquid bromine, it offers outstanding advantages such as high stability, safe handling, mild reaction conditions, and excellent selectivity. It serves as a superior alternative to liquid bromine and is indispensable in industries like pharmaceutical intermediates, steroid synthesis, and fine organic synthesis.
main purpose
α-Bromination of carbonyl groups enables selective bromination at the α-carbon of ketones, phenols, and ethers, widely applied in the synthesis of pharmaceuticals (e.g., β-adrenergic blockers) and steroid compounds.
Electrophilic addition reactions can occur on carbon-carbon double bonds (alkenes) and carbon-carbon triple bonds (alkynes), leading to bromine addition to form vicinal dibromides.
Oxidation reactions can oxidize alcohols and aldehydes into corresponding carbonyl compounds or carboxylic acids.
Selective deprotection can be applied to chemoselective deprotection reactions, such as the removal of TBS protecting groups from primary alcohols.
reaction mechanism
Pyridinium tribromide consists of stable pyridinium cations and tribromide anions. Its mechanism of action involves the in-situ release of bromine molecules in the reaction system, which serve as active electrophilic reagents to participate in the reaction.
This product can slowly and controllably release bromine in solution, effectively avoiding excessive bromination. Compared to the direct use of liquid bromine, it significantly enhances reaction selectivity.
1. Bromination of ketones (enol mechanism)
This reaction typically proceeds under acidic conditions.
Ketone compounds undergo tautomerism, converting into enol structures.
The electron-rich double bond of the enol attacks the electrophilic bromine molecule generated by the reagent.
Subsequently, a proton is removed to form α-bromoketone, along with the generation of hydrogen bromide.
2. Olefin Addition Reaction (Electrophilic Addition)
The π electrons of the alkene attack the bromine molecule, forming a cyclic bromonium ion intermediate.
The bromide ion undergoes a nucleophilic attack from the opposite side of the bromonium ion, resulting in anti-addition and ultimately yielding the orthodibromide.
The tribromopyridinium produced by Shunxiang Pharmaceutical features high quality, excellent stability, high packaging safety, and competitive pricing. With extensive production and transportation experience, Shunxiang Pharmaceutical’s tribromopyridinium has earned the trust and praise of clients both domestically and internationally.